Volcano Corp. swings to Q3 black
Volcano Corp (NSDQ:VOLC) posted profits of $5.6 million, or 10 cents per diluted share, on sales of $72.9 million during the three months ended Sept. 30. That compares with net losses of $4.0 million, or 8 cents per diluted share, on sales of $53.9 million during the same period last year.
Read more
Cardiogenesis pares losses on 30 percent sales boost
Cardiogenesis Corp. (OTC:CGCP) posted net losses of $154,000, or 0 cents per diluted share, on sales of $2.8 million during the three months ended Sept. 30. That compares with net losses of $739,000, or 2 cents per diluted share, on sales of $2.1 million during the same period last year.
Read more
BioMed Realty Trust’s Q3 sales tick up, earnings jump 19 percent
BioMed Realty Trust Inc. (NYSE:BMR) posted profits of $4.8 million, or 4 cents per diluted share, on sales of $95.7 million during the three months ended Sept. 30. That compares with profits of $4.1 million, or 4 cents per diluted share, on sales of $93.0 million during the same period last year.
Read more
BioClinica’s Q3 sales slip, profits tick up
BioClinica Inc. (NSDQ:BIOC) posted profits of $714,000, or 5 cents per diluted share, on sales of $18.2 million during the three months ended Sept. 30. That compares with profits of $701,000, or 5 cents per diluted share, on sales of $18.4 million during the same period last year.
Read more
American Medical Systems’ Q3 sales flat, profits slide
American Medical Systems Holdings Inc. (NSDQ:AMMD) posted profits of $18.6 million, or 24 cents per diluted share, on sales of $124.0 million during the three months ended Oct. 2. That compares with profits of $28.6 million, or 38 cents per diluted share, on sales of $123.2 million during the same period last year.
Read more
Charles River Labs slips into Q3 red
Charles River Laboratories International Inc. (NYSE:CRL) posted a net loss of $24.9 million, or 40 cents per diluted share, on sales of $276.1 million during the three months ended Sept. 25. That compares with profits of $37.3 million, or 57 cents per diluted share, on sales of $297.5 million during the same period last year.
Read more
Cardiovascular Systems pares losses on 20 percent sales gain
Cardiovascular Systems Inc. (NSDQ:CSII) posted net losses of $4.3 million, or 28 cents per diluted share, on sales of $18.2 million during the three months ended Sept. 30. That compares with losses of $6.2 million, or 43 cents per diluted share, on sales of $15.2 million during the same period last year.
Read more
BioMimetic’s Q3 sales flat, losses narrow
BioMimetic Therapeutics Inc. (NSDQ:BMTI) posted losses of $7.8 million, or 29 cents per diluted share, on sales of $378,000 during the three months ended Sept. 30. That compares with losses of $7.9 million, or 36 cents per diluted share, on sales of $375,000 during the same period last year.
Read more
